Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose.
Jeurkar C, Leiby B, Rashid S, Gergis U, Grossso D, Carabasi M, Filicko-O'Hara J, O'Hara W, Klumpp T, Porcu P, Flomenberg N, Wagner JL. Jeurkar C, et al. Among authors: klumpp t. Eur J Haematol. 2024 Sep;113(3):283-289. doi: 10.1111/ejh.14221. Epub 2024 May 6. Eur J Haematol. 2024. PMID: 38711359
Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safety, Research, and Data Interoperability.
Ho VT, Klumpp TR, Liang WH, Prestegaard M, Horwitz M, Hamilton BK, Page K, Jaglowski S, Huber J, Martinez C, Shenoy V, Chen A, Rizzo D. Ho VT, et al. Among authors: klumpp tr. Transplant Cell Ther. 2023 Sep;29(9):539-547. doi: 10.1016/j.jtct.2023.06.014. Epub 2023 Jun 26. Transplant Cell Ther. 2023. PMID: 37379969 Free article.
A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation.
Grosso D, Leiby B, Wilde L, Carabasi M, Filicko-O'Hara J, O'Hara W, Wagner JL, Mateja G, Alpdogan O, Binder A, Kasner M, Keiffer G, Klumpp T, Martinez UO, Palmisiano N, Porcu P, Gergis U, Flomenberg N. Grosso D, et al. Among authors: klumpp t. Transplant Cell Ther. 2022 Dec;28(12):831.e1-831.e7. doi: 10.1016/j.jtct.2022.09.012. Epub 2022 Sep 24. Transplant Cell Ther. 2022. PMID: 36167307 Free article. Clinical Trial.
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on Outcomes.
Grosso D, Carabasi M, Filicko-O'Hara J, Wagner JL, O'Hara W, Sun M, Colombe B, Shi W, Werner-Wasik M, Rudolph S, Alpdogan O, Binder A, Kasner M, Klumpp T, Martinez-Outschoorn U, Palmisiano N, Wilde L, Porcu P, Gergis U, Flomenberg N. Grosso D, et al. Among authors: klumpp t. Biol Blood Marrow Transplant. 2020 Oct;26(10):1861-1867. doi: 10.1016/j.bbmt.2020.06.021. Epub 2020 Jul 3. Biol Blood Marrow Transplant. 2020. PMID: 32629157 Free article.
Autologous Stem Cell Transplantation for Multiple Myeloma: Growth Factor Matters.
Chen J, Pan J, Zhan T, Tuazon S, Saini N, O'Hara W, Filicko-O'Hara J, Klumpp T, Kasner M, Carabasi M, Porcu P, Wagner JL. Chen J, et al. Among authors: klumpp t. Biol Blood Marrow Transplant. 2019 Sep;25(9):e293-e297. doi: 10.1016/j.bbmt.2019.05.035. Epub 2019 Jun 4. Biol Blood Marrow Transplant. 2019. PMID: 31173899 Free article.
149 results